Vascular

Silk Road Medical Inc. has announced the presentation of real-world data from two studies into the treatment of patients with … continue reading “Carotid Artery Disease Patients do Better with TCAR than Endarterectomy”

German company Cardionovum GmbH has updated us with the news that its distribution network, covering 57 countries, is pressing ahead with the commercialisation of its Primus® paclitaxel-coated balloon based on preclinical and clinical support.

Lombard Medical Technologies PLC, is confident it will jump the final hurdles as it gains written feedback from the U.S. FDA on the PMA application for Aorfix™, the Company’s flexible stent graft for the endovascular repair of abdominal aortic aneurysms.

Clinical study results presented this week are being touted as support for the theory that by inducing a three dimensional component into a mechanical stent, its flow characteristics will mimic the natural geometry of human vessels.

Study confirms effectiveness of directional Atherectomy with SilverHawk ™ and TurboHawk ™ Devices as a frontline therapy when treating PAD

With a focus on developing lesion specific solutions for peripheral artery disease, Medtronic, Inc. has announced the U.S. and international launches of the Amphirion Plus Percutaneous Transluminal Angioplasty (PTA) Catheter for the interventional treatment of atherosclerotically narrowed or occluded leg arteries below the knee.

Cook Medical made the Zilver Vena™ Venous Self-Expanding Stent available to physicians across Canada at last week’s 2012 Annual Meeting of the Canadian Society for Vascular Surgery. Designed to restore blood flow in obstructed iliofemoral veins, Cook says the purpose-designed stent provides physicians with a tool designed specifically for the task.

Avery Dennison Medical Solutions has announced that it has received 510(k) clearance from the U.S. FDA for its new Chlorhexidine Gluconate (CHG) transparent film dressing, known as BeneHold™ CHG Transparent Film Dressing.

Biotronik has introduced its Pulsar stent technology in a 0.035″/6F platform, building on what it claims is the success of its Pulsar 18, 0.018″/4F version. It’s also trumpeting a new infrapopliteal PTA balloon called Passeo 14 which it claims offers a new level of utility with the promise of shortened procedure time.

The European market for transcatheter embolization devices is valued at just over €230 million with the leading segment consisting of coil embolics, which currently represents nearly half of the market. A new report from iData Research points to growth in endovascular procedures in general with aging population and growth in predisposing conditions the main drivers.

Presumably with its strong focus on peripheral vascular surgery, Vascular Solutions sees more potential than St.Jude does for this steerable guidewire catheter… enough to pay $3M for residual inventory and rights.

W L Gore’s Hybrod Vascular Graft was FDA cleared two years ago, and now the company has announced it has its CE Mark, which it expects will bring a new level of utility to Vascular Surgeons in Europe.

UK NICE’s guidance on clinical management of Peripheral Artery Disease patients is comprehensive and says they should not be “offered” major amputation unless all other attempts to revascularise have been considered. Strange language, but we know what you mean.

Abbott has announced U.S FDA approval for its Omnilink Elite® Vascular Balloon-Expandable Stent System for the treatment of iliac artery disease. The stent, already CE marked and marketed in Europe, has passed muster with the FDA following a comparative multicentre clinical study which suggested it outperforms endpoints established from previous stent studies..

Teleflex Incorporated has announced that its Semprus BioSciences subsidiary has gained CE mark for its Nylus™ Peripherally Inserted Central Catheter with Semprus Sustain™ technology.

Another in a long line of Californian medtech start-ups, Blockade Medical™ has announced the gaining of CE Mark status for its Barricade Coil System™, designed to remove or endovascularly occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels.